Phone: (602) 307-0070

Fax: (602) 307-0080


Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

The purpose of this study is to determine if apixaban, an investigational anticoagulant (blood-thinner) is as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in subjects with atrial fibrillation and risk factors for stroke.
Sub-Investigator: Nathan Laufer, MD
Sponsor: BMS-Pfizer-PPD
Enrollment Status: Ongoing, closed to enrollment